Private Advisor Group, LLC Penumbra Inc Transaction History

Private Advisor Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$271.54 - $344.06 $159,393 - $201,963	587 New	587 $201,000
Q2 2022 Jul 13, 2022	SELL	$116.09 - $227.33 $104,364 - $204,369	-899 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$187.51 - $283.98 $12,750 - $19,310	68 Added 8.18%	899 $200,000
Q4 2021 Feb 10, 2022	BUY	$238.08 - $288.0 $197,844 - $239,328	831 New	831 $239,000
Q1 2021 Apr 22, 2021	SELL	$175.6 - $291.43 $254,093 - $421,699	-1,447 Closed	0 $0
Q4 2020 Apr 01, 2021	BUY	$174.98 - $272.83 $253,196 - $394,785	1,447 New	1,447 $253,000
Q3 2020 Nov 02, 2020	SELL	$185.27 - $238.73 $103,380 - $133,211	-558 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$153.32 - $191.72 $85,552 - $106,979	558 New	558 $100,000

409

29.2M

254K

43.3K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $11.5B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.